Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17651
Country/Region: Uganda
Year: 2018
Main Partner: IntraHealth International, Inc.
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $6,711,431 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,072,327
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $284,542
Care: Pediatric Care and Support (PDCS) $556,231
Laboratory Infrastructure (HLAB) $55,700
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $616,922
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $498,837
Sexual Prevention: Other Sexual Prevention (HVOP) $235,326
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $492,425
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $2,643,857
Treatment: Pediatric Treatment (PDTX) $255,264
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 77
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 8
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 83
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 5
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 44
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 5
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 8
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 207
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 23
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 264
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 76
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 8
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 1,801
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 197
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 2,404
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 135
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 182
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 20
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 88
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 5
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 877
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 95
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 734
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 41
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 437
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 47
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 310
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 17
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 325
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 35
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 52
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 227
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 24
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 19
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 325
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 35
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 52
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 227
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 24
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 19
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 325
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 35
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 52
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 3
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 227
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 24
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 19
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 107
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 12
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 20
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 77
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 8
GEND_GBV 40-49, Male, Sexual Violence (Post-Rape Care) 2019 7
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 229
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 25
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 30
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 2
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 143
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 15
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 1
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 1,261
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 71
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 5,906
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 640
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 4,198
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 236
GEND_GBV Number of people receiving post-GBV care 2019 10,104
GEND_GBV Number of people receiving post-GBV care 2019 876
HTS_SELF 15-19, Female, Directly-Assisted 2019 27
HTS_SELF 15-19, Female, Directly-Assisted 2019 117
HTS_SELF 15-19, Female, Unassisted 2019 71
HTS_SELF 15-19, Female, Unassisted 2019 305
HTS_SELF 20-24, Female, Directly-Assisted 2019 71
HTS_SELF 20-24, Female, Directly-Assisted 2019 306
HTS_SELF 20-24, Female, Unassisted 2019 214
HTS_SELF 20-24, Female, Unassisted 2019 914
HTS_SELF 20-24, Male, Directly-Assisted 2019 3
HTS_SELF 20-24, Male, Directly-Assisted 2019 15
HTS_SELF 20-24, Male, Unassisted 2019 3
HTS_SELF 20-24, Male, Unassisted 2019 15
HTS_SELF 25-29, Female, Directly-Assisted 2019 43
HTS_SELF 25-29, Female, Directly-Assisted 2019 182
HTS_SELF 25-29, Female, Unassisted 2019 143
HTS_SELF 25-29, Female, Unassisted 2019 609
HTS_SELF 25-29, Male, Directly-Assisted 2019 3
HTS_SELF 25-29, Male, Directly-Assisted 2019 15
HTS_SELF 25-29, Male, Unassisted 2019 3
HTS_SELF 25-29, Male, Unassisted 2019 15
HTS_SELF 30-34, Female, Directly-Assisted 2019 24
HTS_SELF 30-34, Female, Directly-Assisted 2019 105
HTS_SELF 30-34, Female, Unassisted 2019 58
HTS_SELF 30-34, Female, Unassisted 2019 244
HTS_SELF 35-39, Female, Directly-Assisted 2019 10
HTS_SELF 35-39, Female, Directly-Assisted 2019 42
HTS_SELF 35-39, Female, Unassisted 2019 29
HTS_SELF 35-39, Female, Unassisted 2019 122
HTS_SELF 40-49, Female, Directly-Assisted 2019 3
HTS_SELF 40-49, Female, Directly-Assisted 2019 11
HTS_SELF 40-49, Female, Unassisted 2019 7
HTS_SELF 40-49, Female, Unassisted 2019 30
HTS_SELF FSW, Directly-Assisted 2019 36
HTS_SELF FSW, Directly-Assisted 2019 152
HTS_SELF FSW, Unassisted 2019 108
HTS_SELF FSW, Unassisted 2019 456
HTS_SELF MSM, Directly-Assisted 2019 7
HTS_SELF MSM, Directly-Assisted 2019 30
HTS_SELF MSM, Unassisted 2019 7
HTS_SELF MSM, Unassisted 2019 30
HTS_SELF Unassisted - Sex Partner 2019 717
HTS_SELF Unassisted - Sex Partner 2019 3,042
HTS_TST <5, Unknown Sex, Negative 2019 278
HTS_TST <5, Unknown Sex, Negative 2019 366
HTS_TST 15-19, Female, Negative 2019 132
HTS_TST 15-19, Female, Negative 2019 75
HTS_TST 15-19, Male, Negative 2019 49
HTS_TST 15-19, Male, Negative 2019 20
HTS_TST 20-24, Female, Negative 2019 249
HTS_TST 20-24, Female, Negative 2019 138
HTS_TST 20-24, Male, Negative 2019 112
HTS_TST 20-24, Male, Negative 2019 61
HTS_TST 25-29, Female, Negative 2019 57
HTS_TST 25-29, Female, Negative 2019 4,647
HTS_TST 25-29, Female, Negative 2019 9,654
HTS_TST 25-29, Female, Negative 2019 317
HTS_TST 25-29, Female, Negative 2019 92
HTS_TST 25-29, Female, Negative 2019 298
HTS_TST 25-29, Female, Negative 2019 479
HTS_TST 25-29, Female, Negative 2019 527
HTS_TST 25-29, Female, Negative 2019 2,608
HTS_TST 25-29, Female, Negative 2019 912
HTS_TST 25-29, Female, Negative 2019 15,745
HTS_TST 25-29, Female, Negative 2019 2,505
HTS_TST 25-29, Female, Negative 2019 170
HTS_TST 25-29, Female, Negative 2019 626
HTS_TST 25-29, Male, Negative 2019 34
HTS_TST 25-29, Male, Negative 2019 4,777
HTS_TST 25-29, Male, Negative 2019 2,819
HTS_TST 25-29, Male, Negative 2019 203
HTS_TST 25-29, Male, Negative 2019 55
HTS_TST 25-29, Male, Negative 2019 5,101
HTS_TST 25-29, Male, Negative 2019 244
HTS_TST 25-29, Male, Negative 2019 317
HTS_TST 25-29, Male, Negative 2019 435
HTS_TST 25-29, Male, Negative 2019 2,674
HTS_TST 25-29, Male, Negative 2019 601
HTS_TST 25-29, Male, Negative 2019 2,055
HTS_TST 25-29, Male, Negative 2019 114
HTS_TST 25-29, Male, Negative 2019 513
HTS_TST 30-34, Female, Negative 2019 148
HTS_TST 30-34, Female, Negative 2019 66
HTS_TST 30-34, Female, Negative 2019 1,666
HTS_TST 30-34, Female, Negative 2019 4,178
HTS_TST 30-34, Female, Negative 2019 132
HTS_TST 30-34, Female, Negative 2019 111
HTS_TST 30-34, Female, Negative 2019 71
HTS_TST 30-34, Female, Negative 2019 208
HTS_TST 30-34, Female, Negative 2019 127
HTS_TST 30-34, Female, Negative 2019 931
HTS_TST 30-34, Female, Negative 2019 394
HTS_TST 30-34, Female, Negative 2019 6,813
HTS_TST 30-34, Female, Negative 2019 597
HTS_TST 30-34, Female, Negative 2019 75
HTS_TST 30-34, Male, Negative 2019 397
HTS_TST 30-34, Male, Negative 2019 41
HTS_TST 30-34, Male, Negative 2019 3,069
HTS_TST 30-34, Male, Negative 2019 376
HTS_TST 30-34, Male, Negative 2019 133
HTS_TST 30-34, Male, Negative 2019 78
HTS_TST 30-34, Male, Negative 2019 681
HTS_TST 30-34, Male, Negative 2019 189
HTS_TST 30-34, Male, Negative 2019 211
HTS_TST 30-34, Male, Negative 2019 334
HTS_TST 30-34, Male, Negative 2019 1,718
HTS_TST 30-34, Male, Negative 2019 398
HTS_TST 30-34, Male, Negative 2019 1,585
HTS_TST 30-34, Male, Negative 2019 76
HTS_TST 35-39, Female, Negative 2019 281
HTS_TST 35-39, Female, Negative 2019 84
HTS_TST 35-39, Female, Negative 2019 1,839
HTS_TST 35-39, Female, Negative 2019 4,344
HTS_TST 35-39, Female, Negative 2019 137
HTS_TST 35-39, Female, Negative 2019 140
HTS_TST 35-39, Female, Negative 2019 131
HTS_TST 35-39, Female, Negative 2019 215
HTS_TST 35-39, Female, Negative 2019 239
HTS_TST 35-39, Female, Negative 2019 1,027
HTS_TST 35-39, Female, Negative 2019 410
HTS_TST 35-39, Female, Negative 2019 7,068
HTS_TST 35-39, Female, Negative 2019 1,125
HTS_TST 35-39, Female, Negative 2019 77
HTS_TST 35-39, Male, Negative 2019 471
HTS_TST 35-39, Male, Negative 2019 133
HTS_TST 35-39, Male, Negative 2019 3,469
HTS_TST 35-39, Male, Negative 2019 376
HTS_TST 35-39, Male, Negative 2019 181
HTS_TST 35-39, Male, Negative 2019 225
HTS_TST 35-39, Male, Negative 2019 681
HTS_TST 35-39, Male, Negative 2019 230
HTS_TST 35-39, Male, Negative 2019 282
HTS_TST 35-39, Male, Negative 2019 393
HTS_TST 35-39, Male, Negative 2019 1,947
HTS_TST 35-39, Male, Negative 2019 542
HTS_TST 35-39, Male, Negative 2019 1,883
HTS_TST 35-39, Male, Negative 2019 103
HTS_TST 40-49, Female, Negative 2019 259
HTS_TST 40-49, Female, Negative 2019 57
HTS_TST 40-49, Female, Negative 2019 1,494
HTS_TST 40-49, Female, Negative 2019 2,925
HTS_TST 40-49, Female, Negative 2019 95
HTS_TST 40-49, Female, Negative 2019 92
HTS_TST 40-49, Female, Negative 2019 104
HTS_TST 40-49, Female, Negative 2019 145
HTS_TST 40-49, Female, Negative 2019 183
HTS_TST 40-49, Female, Negative 2019 833
HTS_TST 40-49, Female, Negative 2019 277
HTS_TST 40-49, Female, Negative 2019 4,765
HTS_TST 40-49, Female, Negative 2019 1,034
HTS_TST 40-49, Female, Negative 2019 49
HTS_TST 40-49, Male, Negative 2019 599
HTS_TST 40-49, Male, Negative 2019 57
HTS_TST 40-49, Male, Negative 2019 376
HTS_TST 40-49, Male, Negative 2019 2,816
HTS_TST 40-49, Male, Negative 2019 170
HTS_TST 40-49, Male, Negative 2019 92
HTS_TST 40-49, Male, Negative 2019 681
HTS_TST 40-49, Male, Negative 2019 281
HTS_TST 40-49, Male, Negative 2019 261
HTS_TST 40-49, Male, Negative 2019 503
HTS_TST 40-49, Male, Negative 2019 1,575
HTS_TST 40-49, Male, Negative 2019 503
HTS_TST 40-49, Male, Negative 2019 2,389
HTS_TST 40-49, Male, Negative 2019 93
HTS_TST 50+, Female, Negative 2019 5
HTS_TST 50+, Male, Negative 2019 43
HTS_TST 50+, Male, Negative 2019 85
HTS_TST By Key Population: FSW, Negative 2019 156
HTS_TST By Key Population: FSW, Negative 2019 2,874
HTS_TST By Key Population: MSM, Negative 2019 21
HTS_TST By Key Population: MSM, Negative 2019 310
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 1,261
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 7,211
HTS_TST By Key Population: TG, Negative 2019 7
HTS_TST By Key Population: TG, Negative 2019 114
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 145,089
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 117,361
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 439
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 482
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 104
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 121
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 61
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 81
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 224
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 1
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 256
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 483
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 243
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 321
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 899
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 5
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 1,018
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 13,608
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 8,355
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 23,643
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 14,503
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 187
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 252
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 203
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 279
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 41
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 63
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 53
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 104
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 23
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 57
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 94
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 172
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 109
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 187
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 82
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 146
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 1,145
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 710
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 1,242
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 773
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 264
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 165
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 394
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 206
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 127
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 68
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 730
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 384
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 326
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 171
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 6
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 246
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 128
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 1,461
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 1,940
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 1,601
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 2,112
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 337
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 446
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,067
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,900
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 533
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 947
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 1,601
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 2,857
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 1,715
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 3,066
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 14
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 38
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 740
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 1,313
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 2,260
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 3,004
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 57
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 92
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 18
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 40
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 8
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 22
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 79
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 128
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 120
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 195
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 133
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 225
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 57
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 92
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 34
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 55
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 79
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 128
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 470
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 850
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 2,349
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 4,252
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 2,349
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 4,252
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 282
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 510
HTS_TST_POS <5, Unknown Sex, Positive 2019 9
HTS_TST_POS <5, Unknown Sex, Positive 2019 16
HTS_TST_POS 15-19, Female, Positive 2019 10
HTS_TST_POS 15-19, Female, Positive 2019 5
HTS_TST_POS 15-19, Male, Positive 2019 3
HTS_TST_POS 20-24, Female, Positive 2019 21
HTS_TST_POS 20-24, Female, Positive 2019 8
HTS_TST_POS 20-24, Male, Positive 2019 9
HTS_TST_POS 20-24, Male, Positive 2019 2
HTS_TST_POS 25-29, Female, Positive 2019 3
HTS_TST_POS 25-29, Female, Positive 2019 145
HTS_TST_POS 25-29, Female, Positive 2019 99
HTS_TST_POS 25-29, Female, Positive 2019 25
HTS_TST_POS 25-29, Female, Positive 2019 18
HTS_TST_POS 25-29, Female, Positive 2019 49
HTS_TST_POS 25-29, Female, Positive 2019 25
HTS_TST_POS 25-29, Female, Positive 2019 97
HTS_TST_POS 25-29, Female, Positive 2019 81
HTS_TST_POS 25-29, Female, Positive 2019 49
HTS_TST_POS 25-29, Female, Positive 2019 169
HTS_TST_POS 25-29, Female, Positive 2019 104
HTS_TST_POS 25-29, Female, Positive 2019 10
HTS_TST_POS 25-29, Female, Positive 2019 110
HTS_TST_POS 25-29, Male, Positive 2019 88
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 148
HTS_TST_POS 25-29, Male, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 17
HTS_TST_POS 25-29, Male, Positive 2019 11
HTS_TST_POS 25-29, Male, Positive 2019 12
HTS_TST_POS 25-29, Male, Positive 2019 41
HTS_TST_POS 25-29, Male, Positive 2019 18
HTS_TST_POS 25-29, Male, Positive 2019 80
HTS_TST_POS 25-29, Male, Positive 2019 82
HTS_TST_POS 25-29, Male, Positive 2019 30
HTS_TST_POS 25-29, Male, Positive 2019 83
HTS_TST_POS 25-29, Male, Positive 2019 8
HTS_TST_POS 30-34, Female, Positive 2019 28
HTS_TST_POS 30-34, Female, Positive 2019 5
HTS_TST_POS 30-34, Female, Positive 2019 56
HTS_TST_POS 30-34, Female, Positive 2019 74
HTS_TST_POS 30-34, Female, Positive 2019 10
HTS_TST_POS 30-34, Female, Positive 2019 22
HTS_TST_POS 30-34, Female, Positive 2019 10
HTS_TST_POS 30-34, Female, Positive 2019 9
HTS_TST_POS 30-34, Female, Positive 2019 24
HTS_TST_POS 30-34, Female, Positive 2019 24
HTS_TST_POS 30-34, Female, Positive 2019 22
HTS_TST_POS 30-34, Female, Positive 2019 135
HTS_TST_POS 30-34, Female, Positive 2019 26
HTS_TST_POS 30-34, Female, Positive 2019 5
HTS_TST_POS 30-34, Male, Positive 2019 69
HTS_TST_POS 30-34, Male, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 98
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 10
HTS_TST_POS 30-34, Male, Positive 2019 14
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 29
HTS_TST_POS 30-34, Male, Positive 2019 9
HTS_TST_POS 30-34, Male, Positive 2019 65
HTS_TST_POS 30-34, Male, Positive 2019 50
HTS_TST_POS 30-34, Male, Positive 2019 22
HTS_TST_POS 30-34, Male, Positive 2019 66
HTS_TST_POS 30-34, Male, Positive 2019 5
HTS_TST_POS 35-39, Female, Positive 2019 49
HTS_TST_POS 35-39, Female, Positive 2019 7
HTS_TST_POS 35-39, Female, Positive 2019 62
HTS_TST_POS 35-39, Female, Positive 2019 36
HTS_TST_POS 35-39, Female, Positive 2019 10
HTS_TST_POS 35-39, Female, Positive 2019 27
HTS_TST_POS 35-39, Female, Positive 2019 20
HTS_TST_POS 35-39, Female, Positive 2019 9
HTS_TST_POS 35-39, Female, Positive 2019 47
HTS_TST_POS 35-39, Female, Positive 2019 26
HTS_TST_POS 35-39, Female, Positive 2019 23
HTS_TST_POS 35-39, Female, Positive 2019 51
HTS_TST_POS 35-39, Female, Positive 2019 46
HTS_TST_POS 35-39, Female, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 82
HTS_TST_POS 35-39, Male, Positive 2019 16
HTS_TST_POS 35-39, Male, Positive 2019 108
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 15
HTS_TST_POS 35-39, Male, Positive 2019 35
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 37
HTS_TST_POS 35-39, Male, Positive 2019 17
HTS_TST_POS 35-39, Male, Positive 2019 73
HTS_TST_POS 35-39, Male, Positive 2019 60
HTS_TST_POS 35-39, Male, Positive 2019 27
HTS_TST_POS 35-39, Male, Positive 2019 77
HTS_TST_POS 35-39, Male, Positive 2019 8
HTS_TST_POS 40-49, Female, Positive 2019 47
HTS_TST_POS 40-49, Female, Positive 2019 3
HTS_TST_POS 40-49, Female, Positive 2019 52
HTS_TST_POS 40-49, Female, Positive 2019 15
HTS_TST_POS 40-49, Female, Positive 2019 7
HTS_TST_POS 40-49, Female, Positive 2019 18
HTS_TST_POS 40-49, Female, Positive 2019 14
HTS_TST_POS 40-49, Female, Positive 2019 7
HTS_TST_POS 40-49, Female, Positive 2019 38
HTS_TST_POS 40-49, Female, Positive 2019 21
HTS_TST_POS 40-49, Female, Positive 2019 16
HTS_TST_POS 40-49, Female, Positive 2019 15
HTS_TST_POS 40-49, Female, Positive 2019 44
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 8
HTS_TST_POS 40-49, Male, Positive 2019 106
HTS_TST_POS 40-49, Male, Positive 2019 3
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 89
HTS_TST_POS 40-49, Male, Positive 2019 13
HTS_TST_POS 40-49, Male, Positive 2019 18
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 46
HTS_TST_POS 40-49, Male, Positive 2019 14
HTS_TST_POS 40-49, Male, Positive 2019 93
HTS_TST_POS 40-49, Male, Positive 2019 46
HTS_TST_POS 40-49, Male, Positive 2019 26
HTS_TST_POS 40-49, Male, Positive 2019 100
HTS_TST_POS 50+, Male, Positive 2019 1
HTS_TST_POS 50+, Male, Positive 2019 7
HTS_TST_POS By Key Population: FSW, Positive 2019 71
HTS_TST_POS By Key Population: FSW, Positive 2019 1,342
HTS_TST_POS By Key Population: MSM, Positive 2019 9
HTS_TST_POS By Key Population: MSM, Positive 2019 140
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 228
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 1,420
HTS_TST_POS By Key Population: TG, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 38
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 36
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 43
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 149
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 86
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 261
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 149
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 38
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 38
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 50
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 98
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 35
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 1
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 6,683
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 228
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 5,206
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 14
KP_PREV By key population type: Transgender who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 5
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 12,136
PMTCT_ART Already on ART at beginning of current pregnancy 2019 637
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,749
PMTCT_ART New on ART 2019 288
PMTCT_ART New on ART 2019 806
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 925
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 2,555
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 31,831
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 87,434
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 782
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 2,142
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 143
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 413
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 925
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 2,555
PMTCT_EID Sum of Infant Age disaggregates 2019 925
PMTCT_EID Sum of Infant Age disaggregates 2019 2,555
PMTCT_STAT 25-29, Female 2019 19,232
PMTCT_STAT 25-29, Female 2019 7,005
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 782
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 290
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 18,248
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 6,644
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 202
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 71
PMTCT_STAT 30-34, Female 2019 14,862
PMTCT_STAT 30-34, Female 2019 5,412
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 604
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 225
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 14,102
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 5,133
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 156
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 54
PMTCT_STAT 35-39, Female 2019 6,116
PMTCT_STAT 35-39, Female 2019 2,231
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 252
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 93
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 5,803
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 2,114
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 61
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 24
PMTCT_STAT 40-49, Female 2019 1,751
PMTCT_STAT 40-49, Female 2019 636
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 74
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 28
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 1,661
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 600
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 16
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 8
PMTCT_STAT By Age (Numerator): : 15-19 2019 16,615
PMTCT_STAT By Age (Numerator): 15-19 2019 6,044
PMTCT_STAT By Age (Numerator): 20-24 2019 28,858
PMTCT_STAT By Age (Numerator): 20-24 2019 10,503
PMTCT_STAT By known positives: 15-19 2019 9
PMTCT_STAT By known positives: 20-24 2019 50
PMTCT_STAT By new negatives: 15-19 2019 16,434
PMTCT_STAT By new negatives: 20-24 2019 28,504
PMTCT_STAT By new positives: 15-19 2019 172
PMTCT_STAT By new positives: 20-24 2019 304
PMTCT_STAT By Number of known positives: 15-19 2019 4
PMTCT_STAT By Number of known positives: 20-24 2019 18
PMTCT_STAT By Number of new negative: 15-19 2019 5,977
PMTCT_STAT By Number of new negative: 20-24 2019 10,379
PMTCT_STAT By Number of new positives: 15-19 2019 63
PMTCT_STAT By Number of new positives: 20-24 2019 106
PMTCT_STAT Number of new ANC and L&D clients 2019 31,831
PMTCT_STAT Number of new ANC and L&D clients 2019 87,434
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 31,831
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 87,434
PMTCT_STAT_den 25-29, Female 2019 19,232
PMTCT_STAT_den 25-29, Female 2019 7,005
PMTCT_STAT_den 30-34, Female 2019 14,862
PMTCT_STAT_den 30-34, Female 2019 5,412
PMTCT_STAT_den 35-39, Female 2019 6,116
PMTCT_STAT_den 35-39, Female 2019 2,231
PMTCT_STAT_den 40-49, Female 2019 1,751
PMTCT_STAT_den 40-49, Female 2019 636
PMTCT_STAT_den By Age (Denominator): <15-19 2019 6,044
PMTCT_STAT_den By Age (Denominator): 15-19 2019 16,615
PMTCT_STAT_den By Age (Denominator): 20-24 2019 28,858
PMTCT_STAT_den By Age (Denominator): 20-24 2019 10,503
PP_PREV 25-29, Female 2019 157
PP_PREV 25-29, Male 2019 287
PP_PREV 30-34, Female 2019 155
PP_PREV 30-34, Male 2019 284
PP_PREV 35-39, Female 2019 253
PP_PREV 35-39, Male 2019 451
PP_PREV 40-49, Female 2019 263
PP_PREV 40-49, Male 2019 465
PP_PREV Age/sex: 10-14 Female 2019 8
PP_PREV Age/sex: 15-19 Female 2019 415
PP_PREV Age/sex: 15-19 Male 2019 109
PP_PREV Age/sex: 20-24 Female 2019 401
PP_PREV Age/sex: 20-24 Male 2019 291
PP_PREV Age/sex: 50+ Female 2019 171
PP_PREV Age/sex: 50+ Male 2019 303
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 4,013
PP_PREV Sum of Age/Sex disaggregates 2019 1,698
PrEP_NEW 25-29, Female 2019 21
PrEP_NEW 25-29, Male 2019 10
PrEP_NEW 30-34, Female 2019 21
PrEP_NEW 30-34, Male 2019 10
PrEP_NEW 35-39, Female 2019 21
PrEP_NEW 35-39, Male 2019 10
PrEP_NEW 40-49, Female 2019 21
PrEP_NEW 40-49, Male 2019 10
PrEP_NEW Female 15-19 2019 12
PrEP_NEW Female 20-24 2019 47
PrEP_NEW Female 50+ 2019 2
PrEP_NEW FSW 2019 144
PrEP_NEW Male 15-19 2019 2
PrEP_NEW Male 20-24 2019 14
PrEP_NEW Male 50+ 2019 4
PrEP_NEW MSM 2019 8
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 205
PrEP_NEW Other Key Populations 2019 1
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 39
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 27
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 216
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 183
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 37
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 23
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 362
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 320
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 654
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 553
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 4,265
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 3,582
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 492
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 410
TB_PREV By Age/Sex (Numerator): <15, Female 2019 293
TB_PREV By Age/Sex (Numerator): <15, Female 2019 249
TB_PREV By Age/Sex (Numerator): <15, Male 2019 199
TB_PREV By Age/Sex (Numerator): <15, Male 2019 161
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 2,989
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 2,512
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 1,428
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 1,188
TB_PREV IPT, Life-long ART, Already, Positive 2019 128
TB_PREV IPT, Life-long ART, Already, Positive 2019 106
TB_PREV IPT, Life-long ART, New, Positive 2019 24
TB_PREV IPT, Life-long ART, New, Positive 2019 12
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 4,909
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 4,110
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 5,779
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 4,832
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 5,023
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 4,207
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 580
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 482
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 348
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 288
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 232
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 192
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 3,522
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 2,952
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 1,677
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 1,400
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 149
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 126
TB_PREV_den IPT, Life-long ART, New, Positive 2019 27
TB_PREV_den IPT, Life-long ART, New, Positive 2019 17
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 113
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 96
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 682
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 558
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 123
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 104
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,384
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,120
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 2,302
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 1,878
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 2,302
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 1,878
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 113
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 96
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 682
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 558
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 123
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 104
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,384
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,120
TX_CURR 25-29, Female, Positive 2019 2,717
TX_CURR 25-29, Female, Positive 2019 2,156
TX_CURR 25-29, Male, Positive 2019 479
TX_CURR 25-29, Male, Positive 2019 380
TX_CURR 30-34, Female, Positive 2019 3,880
TX_CURR 30-34, Female, Positive 2019 3,085
TX_CURR 30-34, Male, Positive 2019 1,140
TX_CURR 30-34, Male, Positive 2019 905
TX_CURR 35-39, Female, Positive 2019 3,172
TX_CURR 35-39, Female, Positive 2019 2,521
TX_CURR 35-39, Male, Positive 2019 1,486
TX_CURR 35-39, Male, Positive 2019 1,182
TX_CURR 40-49, Female, Positive 2019 4,674
TX_CURR 40-49, Female, Positive 2019 3,709
TX_CURR 40-49, Male, Positive 2019 3,864
TX_CURR 40-49, Male, Positive 2019 3,075
TX_CURR Age/Sex: <1 2019 175
TX_CURR Age/Sex: <1 2019 232
TX_CURR Age/Sex: <1-9 2019 1,067
TX_CURR Age/Sex: 1-9 2019 1,450
TX_CURR Age/Sex: 10-14 Female 2019 874
TX_CURR Age/Sex: 10-14 Female 2019 1,172
TX_CURR Age/Sex: 10-14 Male 2019 377
TX_CURR Age/Sex: 10-14 Male 2019 498
TX_CURR Age/Sex: 15-19 Female 2019 645
TX_CURR Age/Sex: 15-19 Female 2019 507
TX_CURR Age/Sex: 15-19 Male 2019 107
TX_CURR Age/Sex: 15-19 Male 2019 89
TX_CURR Age/Sex: 20-24 Female 2019 1,904
TX_CURR Age/Sex: 20-24 Female 2019 1,511
TX_CURR Age/Sex: 20-24 Male 2019 165
TX_CURR Age/Sex: 20-24 Male 2019 130
TX_CURR Age/Sex: 50+ Female 2019 3,418
TX_CURR Age/Sex: 50+ Female 2019 2,717
TX_CURR Age/Sex: 50+ Male 2019 2,279
TX_CURR Age/Sex: 50+ Male 2019 1,809
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 32,423
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 27,128
TX_CURR Sum of age/sex disaggregates 2019 752
TX_CURR Sum of Age/Sex disaggregations 2019 596
TX_NEW 25-29, Female, Positive 2019 501
TX_NEW 25-29, Female, Positive 2019 448
TX_NEW 25-29, Male, Positive 2019 342
TX_NEW 25-29, Male, Positive 2019 260
TX_NEW 30-34, Female, Positive 2019 225
TX_NEW 30-34, Female, Positive 2019 170
TX_NEW 30-34, Male, Positive 2019 228
TX_NEW 30-34, Male, Positive 2019 173
TX_NEW 35-39, Female, Positive 2019 234
TX_NEW 35-39, Female, Positive 2019 179
TX_NEW 35-39, Male, Positive 2019 305
TX_NEW 35-39, Male, Positive 2019 236
TX_NEW 40-49, Female, Positive 2019 157
TX_NEW 40-49, Female, Positive 2019 120
TX_NEW 40-49, Male, Positive 2019 286
TX_NEW 40-49, Male, Positive 2019 219
TX_NEW Breastfeeding status 2019 334
TX_NEW Breastfeeding status 2019 256
TX_NEW By Age/Sex: <1 2019 22
TX_NEW By Age/Sex: <1 2019 13
TX_NEW By Age/Sex: 1-9 2019 105
TX_NEW By Age/Sex: 1-9 2019 103
TX_NEW By Age/Sex: 10-14 Female 2019 94
TX_NEW By Age/Sex: 10-14 Female 2019 95
TX_NEW By Age/Sex: 10-14 Male 2019 28
TX_NEW By Age/Sex: 10-14 Male 2019 20
TX_NEW By Age/Sex: 15-19 Female 2019 224
TX_NEW By Age/Sex: 15-19 Female 2019 170
TX_NEW By Age/Sex: 15-19 Male 2019 76
TX_NEW By Age/Sex: 15-19 Male 2019 51
TX_NEW By Age/Sex: 20-24 Female 2019 414
TX_NEW By Age/Sex: 20-24 Female 2019 314
TX_NEW By Age/Sex: 20-24 Male 2019 183
TX_NEW By Age/Sex: 20-24 Male 2019 137
TX_NEW By Age/Sex: 50+ Female 2019 9
TX_NEW By Age/Sex: 50+ Female 2019 6
TX_NEW By Age/Sex: 50+ Male 2019 136
TX_NEW By Age/Sex: 50+ Male 2019 106
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 3,569
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 2,820
TX_NEW Pregnancy status 2019 334
TX_NEW Pregnancy status 2019 256
TX_NEW Sum of Age/Sex disaggregates 2019 1,164
TX_NEW Sum of Age/Sex disaggregates 2019 899
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 24,414
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 29,183
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 1,170
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 975
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 133
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 163
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 588
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 484
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 65
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 83
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 16,040
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 13,438
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 2,027
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 2,411
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 7,591
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 6,345
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 947
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 1,137
TX_PVLS_den Denominator: Indication: Routine 2019 21,242
TX_PVLS_den Denominator: Indication: Routine 2019 25,389
TX_PVLS_den Denominator: Indication: Targeted 2019 3,172
TX_PVLS_den Denominator: Indication: Targeted 2019 3,794
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 133
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 260
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 72
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 138
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,297
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,786
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,931
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,460
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 6,433
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 5,644
TX_RET Numerator by Status: Breastfeeding 2019 625
TX_RET Numerator by Status: Breastfeeding 2019 525
TX_RET Numerator by Status: Pregnant 2019 625
TX_RET Numerator by Status: Pregnant 2019 525
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 7,148
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 6,268
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 149
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 287
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 79
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 153
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,663
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,094
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,257
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 2,734
TX_RET_den Denominator by Status: Breastfeeding 2019 696
TX_RET_den Denominator by Status: Breastfeeding 2019 583
TX_RET_den Denominator by Status: Pregnant 2019 696
TX_RET_den Denominator by Status: Pregnant 2019 583
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 32,423
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 27,128
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 1,945
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 1,627
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 1,296
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 1,085
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 16,551
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 7,865
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 19,778
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 9,404
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 965
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 818
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 71
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 50
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 260
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 217
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 1,085
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 1,296
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 28,204
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 23,605
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 849
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 700
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 3,241
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 2,714
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 129
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 109
VMMC_CIRC 30-34, Male 2019 1,058
VMMC_CIRC 35-39, Male 2019 1,058
VMMC_CIRC 40-49, Male 2019 1,058
VMMC_CIRC By Age: 10-14 2019 1,324
VMMC_CIRC By Age: 15-19 2019 6,615
VMMC_CIRC By Age: 20-24 2019 6,615
VMMC_CIRC By Age: 25-29 2019 7,940
VMMC_CIRC By Age: 50+ 2019 785
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 26,453
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 26,453
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 23,279
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 15,339
Cross Cutting Budget Categories and Known Amounts Total: $626,202
Key Populations: MSM and TG $17,814
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Monitoring and evaluation of MSM/TG programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Key Populations: Sex Workers $26,721
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Gender: Gender Based Violence (GBV) $250,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $31,969
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Condoms: Policy, Tools, and Services $71,256
Water $175,000
Food and Nutrition: Policy, Tools, and Service Delivery $53,442